US Broker Ratings

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Exploring a 20% Potential Upside in the Biotech Sector

Arbutus Biopharma Corporation (NASDAQ: ABUS) is gaining attention in the biotechnology sector, driven by its promising pipeline focused on novel therapeutics for infectious diseases, particularly chronic Hepatitis B. With a..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Navigating a 40% Potential Upside with Strategic Growth

OrthoPediatrics Corp. (NASDAQ: KIDS), a prominent player in the healthcare sector focusing on medical devices, presents a compelling opportunity for investors seeking growth in the pediatric orthopedic market. With a..

Kamada Ltd. (KMDA) Stock Analysis: Unveiling a 57% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Kamada Ltd. (NASDAQ: KMDA) presents a compelling case with its significant potential upside of 57.38%. This Israeli-based company, operating in the drug..

SIGA Technologies Inc. (SIGA) Stock Analysis: Assessing Opportunities in the Health Security Sector

SIGA Technologies Inc. (NASDAQ: SIGA), a prominent player in the health security sector, has attracted attention with its commercial-stage pharmaceutical operations, particularly centered around its antiviral drug, TPOXX. As a..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Unpacking a Promising 188% Upside in Biotech Innovation

Investors with a keen eye on the biotechnology sector should take a closer look at MeiraGTx Holdings plc (NASDAQ: MGTX). Known for its cutting-edge work in genetic medicines, MeiraGTx stands..

Cel-Sci Corporation (CVM) Stock Analysis: Exploring the Potential of a Biotech Challenger with a Unique Immunotherapy Approach

Cel-Sci Corporation (NASDAQ: CVM), a clinical-stage biotechnology firm, is carving a niche in the healthcare sector with its innovative approach to cancer treatment. Headquartered in Vienna, Virginia, this company is..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: A 34% Upside Potential in the Biotech Sector

Investors with an eye on the burgeoning biotechnology sector may find Rapport Therapeutics, Inc. (NASDAQ: RAPP) a compelling opportunity, especially with a potential upside of 34.23% as suggested by analyst..

Xencor, Inc. (XNCR) Stock Analysis: Exploring a 132% Potential Upside in Biotech

Xencor, Inc. (NASDAQ: XNCR) has captured investor attention with its promising pipeline of engineered antibodies targeting cancer and autoimmune diseases. As a clinical-stage biopharmaceutical company, Xencor’s focus on innovative treatments..

Septerna, Inc. (SEPN) Stock Analysis: Unpacking a Potential 84% Upside in the Healthcare Biotech Arena

Septerna, Inc. (NASDAQ: SEPN) is capturing investor attention with its promising position in the biotechnology sector, focusing on breakthrough therapies for complex and underserved medical conditions. With a market cap..

Organogenesis Holdings Inc. (ORGO) Stock Report: Exploring a Potential 216% Upside

Organogenesis Holdings Inc. (NASDAQ: ORGO) is catching the eye of investors with a compelling potential upside of 216.21%, according to recent analyst ratings. This regenerative medicine company, with a market..

Emergent BioSolutions Inc. (EBS): Investor Outlook with a Promising 31.43% Potential Upside

Emergent BioSolutions Inc. (NASDAQ: EBS), a key player in the healthcare sector, is garnering attention with an enticing potential upside of 31.43%. Investors are eyeing this company as it navigates..

Autolus Therapeutics plc (AUTL): Analyst Ratings Illuminate 438.99% Potential Upside in Biotech Stock

Autolus Therapeutics plc (NASDAQ: AUTL), a UK-based clinical-stage biopharmaceutical company, has captured the attention of investors with its promising pipeline of T cell therapies targeting cancer and autoimmune diseases. Operating..

STAAR Surgical (STAA) Stock Analysis: Navigating the Potential in Visionary Healthcare

STAAR Surgical Company (NASDAQ: STAA), a significant player in the Medical Instruments & Supplies industry, has been making waves with its innovative approaches to vision correction. Headquartered in Lake Forest,..

Akebia Therapeutics, Inc. (AKBA) Investor Outlook: A Biotech with Significant Upside Potential

Akebia Therapeutics, Inc. (NASDAQ: AKBA) presents an intriguing opportunity for investors in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a current market cap of..

AngioDynamics, Inc. (ANGO) Investor Outlook: Analyzing a 59.72% Potential Upside

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, stands out for its innovative contributions to medical technology. Headquartered in Latham, New York, AngioDynamics designs and manufactures medical..

Butterfly Network, Inc. (BFLY) Stock Analysis: Exploring a 34% Potential Upside

Butterfly Network, Inc. (NYSE: BFLY), a prominent player in the healthcare sector, particularly in the medical devices industry, has been capturing the attention of investors with its innovative ultrasound imaging..

Celcuity Inc. (CELC) Stock Analysis: Biotechnology Innovator with a 20.5% Potential Upside

Celcuity Inc. (NASDAQ: CELC) stands out in the competitive biotechnology sector with its promising pipeline and strategic partnerships. Despite a recent minor dip of 0.06% in stock price, Celcuity’s market..

AxoGen, Inc. (AXGN) Stock Analysis: 17% Upside Potential Amid Robust Revenue Growth

AxoGen, Inc. (NASDAQ: AXGN), a key player in the healthcare sector specializing in medical devices for peripheral nerve regeneration, is capturing the attention of investors due to its impressive market..

Humacyte, Inc. (HUMA) Stock Analysis: Exploring a Potential 369% Upside in the Biotech Sector

For investors with a keen eye on the healthcare sector, Humacyte, Inc. (NASDAQ: HUMA) presents an intriguing opportunity. As a biotechnology company specializing in the development of bioengineered human tissues,..

LifeMD, Inc. (LFMD) Stock Analysis: A Telehealth Contender with a Promising 119.93% Upside

LifeMD, Inc. (LFMD) stands at a pivotal point in the healthcare industry as a direct-to-patient telehealth pioneer, serving the U.S. market with a spectrum of medical services and pharmacy solutions...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds